Assessing the risk of cardiovascular events in patients receiving immune checkpoint inhibitors.
Torrente M, Blanco M, Franco F, Garitaonaindia Y, Calvo V, Collazo-Lorduy A, Gutiérrez L, Sánchez JC, González-Del-Alba A, Hernández R, Méndez M, Cantos B, Núñez B, Sousa PAC, Provencio M.
Torrente M, et al. Among authors: cantos b.
Front Cardiovasc Med. 2022 Dec 1;9:1062858. doi: 10.3389/fcvm.2022.1062858. eCollection 2022.
Front Cardiovasc Med. 2022.
PMID: 36531707
Free PMC article.